Botulinum neurotoxin serotype C: A novel effective botulinum toxin therapy in human

Neuroscience Letters

Volumn 224, Issue 2, 1997, Pages 91-94

  Eleopra, Roberto ^a   Tugnoli, Valeria ^a   Rossetto, Ornella ^b   Montecucco, Cesare ^b   De Grandis, Domenico ^a  

^a SANT ANNA HOSPITAL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

botulinum toxin C; dystonia; electrophysiology

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; BLEPHAROSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSTONIA; ELECTROPHYSIOLOGY; ELECTROSTIMULATION; FACE HEMISPASM; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PERONEUS NERVE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BOTULINUM TOXIN TYPE A; BOTULINUM TOXINS; DRUG RESISTANCE; DYSTONIA; ELECTROPHYSIOLOGY; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 0030901704     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)13448-6     Document Type: Article

References (11)

1. Borodic, G., Johnson, E., Goodnough, M. and Schantz, E., Botulinum toxin therapy, immunologic resistance, and problems with available materials, Neurology, 46 (1996) 26-29.
2. Eleopra, R., Tugnoli, V. and De Grandis, D., The variability in the clinical effect induced by botulinum toxin type A: the role of muscle activity in humans, Movement Disorders, 12(1) (1997) 89-94.
3. Greene, P.E. and Fahn, S., Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A, Movement Disorders, 8 (1993) 479-483.
4. Hamjian, J.A. and Walker, F.O., Serial neurophysiological studies of intramuscular botulinum A toxin in humans, Muscle Nerve, 17 (1994) 1385-1392.
5. Jankovic, J. and Hallett, M., Therapy with Botulinum Toxin, Marcel Dekker, New York, 1994.
6. Jankovic, J. and Schwartz, K., Response and immunoresistance to botulinum toxin injections, Neurology, 45 (1995) 1743-1746.
7. Ludlow, C.L., Hallett, M., Rhew, K., Cola, R., Shimizu, T., Sakaguchi, G., Bagley, J.A., Schulz, G.M., Yin, S.G. and Koda, J., Therapeutic use of type F botulinum toxin, N. Engl. J. Med., 326 (1992) 349-350.
8. Mezaki, T., Kaji, R., Kohara, N., Fujii, H., Katayama, M., Shimizu, T., Kimura, J. and Brin, M.F., Comparison of therapeutic efficacies of type A and F botulinum toxins for blepharospasm: a double-blind, controlled study, Neurology, 45 (1995) 506-508.
9. Montecucco, C. and Schiavo, G., Mechanism of action of tetanus and botulinum neurotoxins, Quart. Rev. Biophys., 28 (1994) 423-472.
10. Oguma, K., Yokota, K., Hayashi, S., Takeshi, M., Kumagai, M., Itoh, N., Tachi, N. and Chiba, S., Infant botulism due to clostridium botulinum type C toxin, Lancet, 336 (1990) 1449-1450.
11. Tsui, J.K.C., Hayward, M., Ming Mak, E.K. and Schulzer, M., Botulinum toxin type B in the treatment of cervical dystonia: a pilot study, Neurology, 45 (1995) 2109-2110.